Howard A. Burris
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Lung Cancer Treatments and Mutations, HER2/EGFR in Cancer Research, Colorectal Cancer Treatments and Studies, Advanced Breast Cancer Therapies
Most-Cited Works
- → Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.(1997)5,865 cited
- → Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial(2016)3,687 cited
- → Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer(2011)2,803 cited
- → Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations(2012)2,783 cited
- → MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer(2014)2,412 cited
- → Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer(2016)1,956 cited
- → Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial(2017)1,281 cited
- → Capecitabine as Adjuvant Treatment for Stage III Colon Cancer(2005)1,245 cited
- → Expression of Epiregulin and Amphiregulin and K-ras Mutation Status Predict Disease Control in Metastatic Colorectal Cancer Patients Treated With Cetuximab(2007)1,126 cited
- → Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer(2022)1,014 cited